New data published by the UK Health Security Agency (UKHSA) has revealed that London is potentially at risk of a measles resurgence.
UKHSA modelling suggests that, unless MMR vaccination rates improve, London could see a measles outbreak with tens of thousands of cases.
"Those who have never received a measles vaccine (MMR) are at risk," said UKHSA.
MMR is part of the NHS Routine Childhood Immunisation Programme. Parents whose infants missed out, or anyone of any age unvaccinated, are urged to come forward.
Susceptibility is particularly high among 19 to 25 year olds, affected by unfounded stories in the early 2000s ('Wakefield cohorts') and some may still not be
fully vaccinated.
As part of continued efforts to protect people against getting measles, the NHS is launching a campaign encouraging people to check their vaccination status, with
targeted outreach to groups in London.
In a collaborative effort, the National Health Services England (NHSE) is set to deliver the RSV(respiratory syncytial virus) vaccination programme where
pharmacists alongside other healthcare professionals will play a crucial role in administering the vaccine.
The UK Health Security Agency has announced the launch of the new vaccination programme targeting the respiratory syncytial virus (RSV), set to begin on 1 September
2024.
Along with GPs, NHS England (NHSE) will "commission a number of community pharmacies to deliver the programme", ensuring broad accessibility and coverage to protect
two high-risk groups: older adults and pregnant women.
RSV is an RNA virus related to mumps, measles, and human parainfluenza viruses.
It commonly causes coughs and colds in winter, transmitted through droplets and secretions from close contact with infected individuals.
While most RSV infections are mild, infants under six months and the elderly are particularly susceptible to severe diseases like bronchiolitis and pneumonia,
which can lead to hospitalisation.